Salauze D, Cave D
Rhone-Poulenc Rorer SA, Drug Safety Department, Vitry, France.
Lab Anim. 1995 Oct;29(4):432-7. doi: 10.1258/002367795780740087.
A study to assess the toxic potential of a candidate-drug administered to unrestrained rats as 1-h infusions thrice daily for 3 months, using 5% glucose as vehicle, had to be aborted on day 34 because of poor physical status and mortalities in all groups, including controls receiving the vehicle alone. Investigation demonstrated an opportunistic infection, probably secondary to the glucose present in the intravenous formulation. A second study using 0.9% saline solution as a vehicle, was successfully completed.
一项旨在评估一种候选药物毒性潜力的研究,该药物以5%葡萄糖为溶媒,每日三次、每次1小时静脉输注给无约束大鼠,持续3个月。但在第34天因所有组(包括仅接受溶媒的对照组)大鼠身体状况不佳和出现死亡而不得不中止。调查显示这是一次机会性感染,可能继发于静脉制剂中的葡萄糖。第二项研究使用0.9%生理盐水作为溶媒,已成功完成。